Due to the issuance of new shares in the rights issue announced on
Changes have been made to both the subscription price of the warrants and the number of Brighter shares that each warrant entitle subscription for. Information on the recalculated terms is shown below:
Warrants Series TO5
The subscription price in the TO5 series is, after recalculation,
The number of Brighter shares that each warrant in the TO5 series entitles subscription for after the recalculation, is 1.65. Prior to the recalculation, 1 warrant entitled subscription of 1 share.
The remaining subscription periods in series TO5 are
· 22 May -
· 20 November -
· 21 May -
· 22 November -
· 23 May -
· 21 November -
· 23 May -
Complete terms
Complete terms for warrant series TO3, TO4 and TO5 can be found on Brighter's website, https://brighter.se/investors/financing-home/warrants.
For further information, please contact:
Phone: +46 708 37 21 23
Email: ann.zetterberg@brighter.se
Henrik Norström, CEO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
About
Brighter is a health-tech company from
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter's Certified Adviser is
https://news.cision.com/brighter-ab--publ-/r/recalculation-of-warrants-in-series-to5,c3009340
https://mb.cision.com/Main/13292/3009340/1174737.pdf
(c) 2020 Cision. All rights reserved., source